Is Ozempic Available in India? The Complete 2026 Guide
With the 2026 patent expiry, semaglutide access in India has been revolutionized. We cover the new generic launches, official pricing, and legal access.
With the 2026 patent expiry, semaglutide access in India has been revolutionized. We cover the new generic launches, official pricing, and legal access.
With the 2026 launch of affordable generics, millions more Indians are starting GLP-1s. Here is the updated safety profile, including new Ministry of Health warnings.
Tirzepatide has officially landed for both diabetes and weight loss in India. Here is the updated 2026 data on costs, brands, and clinical outcomes.
For decades, Indians treated weight loss as a test of character. In 2026, the science of GLP-1 is proving that the struggle is biological, not moral.